Clinical severity of Alzheimer's disease is associated with PIB uptake in PET

被引:68
作者
Grimmer, Timo [1 ]
Henriksen, Gjermund [2 ]
Wester, Hans-Juergen [2 ]
Foerstl, Hans
Klunk, William E. [3 ]
Mathis, Chester A. [4 ]
Kurz, Alexander
Drzezga, Alexander [2 ]
机构
[1] Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Psychiat & Psychotherapie, Dept Psychiat & Psychotherapy, D-81675 Munich, Germany
[2] Tech Univ Munich, Klinikum Rechts Isar, Dept Nucl Med, D-81675 Munich, Germany
[3] Western Psychiat Inst & Clin, Dept Psychiat, Pittsburgh, PA 15213 USA
[4] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15213 USA
关键词
Alzheimer's disease; Dementia; Clinical Dementia Rating; Amyloid plaques; Positron emission tomography; Imaging; 18F]FDG; 11C]PIB; Pittsburgh Compound B; CEREBRAL GLUCOSE-METABOLISM; PITTSBURGH COMPOUND-B; AMYLOID DEPOSITION; DEMENTIA; PLAQUES; BRAIN; AD; NEUROPATHOLOGY; DIAGNOSIS; CRITERIA;
D O I
10.1016/j.neurobiolaging.2008.01.016
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background: The positron emission tomography (PET) tracer [11C]-Pittsburgh Compound-B ([11C]PIB) allows the in vivo assessment of amyloid plaque burden in the brain. In a cross-sectional study we examined the association between the seventy of dementia assessed using the Clinical Dementia Rating scale sum of boxes (CDR-SOB) and [11C]PIB-PET in patients with Alzheimer's disease (AD). Methods: Patients with probable AD who had an AD-typical [18F]FDG-PET scan were included Linear regression analysis in anatomically defined regions-of-interest (ROIs) and correlation analysis using statistical parametric mapping (SPM) were used to determine the association between CDR-SOB and [11C]PIB uptake. Results: The linear regression analyses showed that the CDR-SOB explained approximately 11-22% of the variance of [11C]PIB uptake. The association attained statistical significance in both frontal, in both anterior cingulate cortices, and in both putamina. The SPM analysis showed a significant association in more widespread regions of the brain, with maxima located in similar areas as in the ROI-analysis. Conclusion: The CDR-SOB score is significantly associated with [11C]PIB uptake in patients with AD Thus [11C]PIB is a potential surrogate marker of dementia severity. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:1902 / 1909
页数:8
相关论文
共 50 条
  • [31] 24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderate-to-Severe Alzheimer's Disease: Analyses from a Clinical Trial with Nabilone
    Ruthirakuhan, Myuri
    Herrmann, Nathan
    Andreazza, Ana C.
    Verhoeff, Nicolaas Paul L. G.
    Gallagher, Damien
    Black, Sandra E.
    Kiss, Alex
    Lanctot, Krista L.
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 71 (01) : 21 - 31
  • [32] Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology
    Laforce, Robert, Jr.
    Tosun, Duygu
    Ghosh, Pia
    Lehmann, Manja
    Madison, Cindee M.
    Weiner, Michael W.
    Miller, Bruce L.
    Jagust, William J.
    Rabinovici, Gil D.
    NEUROIMAGE-CLINICAL, 2014, 4 : 508 - 516
  • [33] Deep White Matter Lesions Are Associated with Early Recognition of Dementia in Alzheimer's Disease
    Kasahara, Hiroo
    Ikeda, Masaki
    Nagashima, Kazuaki
    Fujita, Yukio
    Makioka, Kouki
    Tsukagoshi, Setsuki
    Yamazaki, Tsuneo
    Takai, Eriko
    Sanada, Etsuko
    Kobayashi, Ayumi
    Kishi, Kazuhiro
    Suto, Takayuki
    Higuchi, Tetsuya
    Tsushima, Yoshito
    Ikeda, Yoshio
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 68 (02) : 797 - 808
  • [34] Towards clinical application of tau PET tracers for diagnosing dementia due to Alzheimer's disease
    Ossenkoppele, Rik
    Hansson, Oskar
    ALZHEIMERS & DEMENTIA, 2021, 17 (12) : 1998 - 2008
  • [35] Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease
    Chetelat, Gael
    Ossenkoppele, Rik
    Villemagne, Victor L.
    Perrotin, Audrey
    Landeau, Brigitte
    Mezenge, Florence
    Jagust, William J.
    Dore, Vincent
    Miller, Bruce L.
    Egret, Stephanie
    Seeley, William W.
    van der Flier, Wiesje M.
    La Joie, Renaud
    Ames, David
    van Berckel, Bart N. M.
    Scheltens, Philip
    Barkhof, Frederik
    Rowe, Christopher C.
    Masters, Colin L.
    de La Sayette, Vincent
    Bouwman, Femke
    Rabinovici, Gil D.
    BRAIN, 2016, 139 : 2528 - 2539
  • [36] Clinical Applications of PET Imaging in Alzheimer's Disease
    Patil, Shiv
    Ayubcha, Cyrus
    Teichner, Eric
    Subtirelu, Robert
    Cho, Julia H.
    Ghonim, Mohanad
    Ghonim, Mohamed
    Werner, Thomas J.
    Flemming, Poul
    Hoilund-Carlsen, Poul Flemming
    Alavi, Abass
    Newberg, Andrew B.
    PET CLINICS, 2025, 20 (01) : 89 - 100
  • [37] [18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer's disease
    Hatashita, Shizuo
    Yamasaki, Hidetomo
    Suzuki, Yutaka
    Tanaka, Kumiko
    Wakebe, Daichi
    Hayakawa, Hideki
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (02) : 290 - 300
  • [38] Olfactory Deficits and Amyloid-β Burden in Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Aging: A PiB PET Study
    Bahar-Fuchs, Alex
    Chetelat, Gael
    Villemagne, Victor L.
    Moss, Simon
    Pike, Kerryn
    Masters, Colin L.
    Rowe, Christopher
    Savage, Greg
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 22 (04) : 1081 - 1087
  • [39] Progression of Cerebral Amyloid Load Is Associated with the Apolipoprotein E ε4 Genotype in Alzheimer's Disease
    Grimmer, Timo
    Tholen, Susanne
    Yousefi, Behrooz H.
    Alexopoulos, Panagiotis
    Forschler, Annette
    Forstl, Hans
    Henriksen, Gjermund
    Klunk, William E.
    Mathis, Chester A.
    Perneczky, Robert
    Sorg, Christian
    Kurz, Alexander
    Drzezga, Alexander
    BIOLOGICAL PSYCHIATRY, 2010, 68 (10) : 879 - 884
  • [40] Classification of Clinically Diagnosed Alzheimer's Disease Associated with Diabetes Based on Amyloid and Tau PET Results
    Takenoshita, Naoto
    Shimizu, Soichiro
    Kanetaka, Hidekazu
    Sakurai, Hirofumi
    Suzuki, Ryo
    Miwa, Takashi
    Odawara, Masato
    Ishii, Kenji
    Shimada, Hitoshi
    Higuchi, Makoto
    Suhara, Tetsuya
    Hanyu, Haruo
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 71 (01) : 261 - 271